These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 3029222)

  • 1. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent activation of C1, the first component of complement, by cardiolipin.
    Kovacsovics T; Tschopp J; Kress A; Isliker H
    J Immunol; 1985 Oct; 135(4):2695-700. PubMed ID: 4031497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody density on rat red cells determines the rate of activation of the complement component C1.
    Hughes-Jones NC; Gorick BD; Howard JC; Feinstein A
    Eur J Immunol; 1985 Oct; 15(10):976-80. PubMed ID: 2996908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of C1r by proteolytic cleavage.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.